Acadia Pharmaceuticals Inc. · NASDAQ:ACAD

Ndu Adora exercised options for 8,107 Acadia Pharmaceuticals Inc. shares (Form 4)

Traded May 29, 2026 · Filed Jun 1, 2026

On May 29, 2026, Ndu Adora (Director) exercised options for 8,107 Acadia Pharmaceuticals Inc. shares, leaving 32,908 shares. Filed Jun 1, 2026 (Form 4).

Options exercised
8,107 shares
Holding after
32,908 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 29, 2026Common StockOption exercise8,10732,908Direct

Source

View original at SEC

Related